Quarterly Call Option Transactions in Arcus Biosciences, Inc. (RCUS)
This table provides information about the institutional ownership of Arcus Biosciences, Inc. (RCUS) during . The information is specifically focused on institutions that hold call options of Arcus Biosciences, Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 0 | 135,725 | 135,725 | 13,700 | 4,900 | 18,600 | 117,125 | |
| Q4 2021 | 0 | 32,700 | 32,700 | 21,300 | 0 | 21,300 | 11,400 | |
| Q1 2022 | 66,500 | 275,600 | 342,100 | 43,000 | 31,700 | 74,700 | 267,400 | |
| Q2 2022 | 46,000 | 0 | 46,000 | 202,200 | 23,500 | 225,700 | -179,700 | |
| Q3 2022 | 14,200 | 0 | 14,200 | 126,600 | 0 | 126,600 | -112,400 | |
| Q4 2022 | 105,800 | 45,200 | 151,000 | — | 151,000 | |||
| Q1 2023 | 117,700 | 143,808 | 261,508 | — | 261,508 | |||
| Q2 2023 | 578,500 | 201,000 | 779,500 | 86,400 | 0 | 86,400 | 693,100 | |
| Q3 2023 | 3,100 | 61,600 | 64,700 | 682,100 | 0 | 682,100 | -617,400 | |
| Q4 2023 | 396,700 | 50,000 | 446,700 | 80,800 | 0 | 80,800 | 365,900 | |
| Q1 2024 | 12,100 | 102,000 | 114,100 | — | 114,100 | |||
| Q2 2024 | 400 | 49,300 | 49,700 | 53,600 | 0 | 53,600 | -3,900 | |
| Q3 2024 | 12,900 | 146,900 | 159,800 | 20,800 | 0 | 20,800 | 139,000 | |